Skip to main content

Argenica knocked back by US FDA

2 days ago

Bookmark

Save articles for future reference.

Perth-based neurological drug developer Argenica Therapeutics has been knocked back by the US Food and Drug Administration, dashing hopes its US clinical trials would soon start.

X

To read our articles you will need to either login or subscribe.